Publication Information

{'id': 'https://openalex.org/W2361590022', 'doi': None, 'title': 'Parmacokinetics and bioequivalence of compound valsartan tablets in healthy volunteers', 'display_name': 'Parmacokinetics and bioequivalence of compound valsartan tablets in healthy volunteers', 'publication_year': 2006, 'publication_date': '2006-01-01', 'ids': {'openalex': 'https://openalex.org/W2361590022', 'mag': '2361590022'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-GLYZ200601014.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764396500', 'display_name': 'The Chinese Journal of Clinical Pharmacology', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4320800687', 'host_organization_name': 'Chinese Pharmaceutical Association', 'host_organization_lineage': ['https://openalex.org/P4320800687'], 'host_organization_lineage_names': ['Chinese Pharmaceutical Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5105300983', 'display_name': 'Chen Ying', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Chen Ying', 'raw_affiliation_strings': [', WANG De-zhi2,LI Yang1 , CHEN Jin-yang3, LI Ke-xin1, LIU Lei1, SUN Chun-hua1'], 'affiliations': [{'raw_affiliation_string': ', WANG De-zhi2,LI Yang1 , CHEN Jin-yang3, LI Ke-xin1, LIU Lei1, SUN Chun-hua1', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5105300983'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Licorice Roots', 'score': 0.9909, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Licorice Roots', 'score': 0.9909, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11385', 'display_name': 'Biological Activities of Triterpenoids and Saponins', 'score': 0.9897, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T14331', 'display_name': 'Ethnopharmacological and Phytochemical Properties of Epimedium Genus', 'score': 0.987, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/bioequivalence', 'display_name': 'Bioequivalence', 'score': 0.9648689}, {'id': 'https://openalex.org/keywords/pharmacological-properties', 'display_name': 'Pharmacological Properties', 'score': 0.51815}], 'concepts': [{'id': 'https://openalex.org/C42404028', 'wikidata': 'https://www.wikidata.org/wiki/Q864940', 'display_name': 'Bioequivalence', 'level': 3, 'score': 0.9648689}, {'id': 'https://openalex.org/C2777387769', 'wikidata': 'https://www.wikidata.org/wiki/Q155472', 'display_name': 'Valsartan', 'level': 3, 'score': 0.9087001}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.82353}, {'id': 'https://openalex.org/C2780361556', 'wikidata': 'https://www.wikidata.org/wiki/Q423930', 'display_name': 'Hydrochlorothiazide', 'level': 3, 'score': 0.7549755}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5892594}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.48448488}, {'id': 'https://openalex.org/C179998833', 'wikidata': 'https://www.wikidata.org/wiki/Q381233', 'display_name': 'High-performance liquid chromatography', 'level': 2, 'score': 0.4284641}, {'id': 'https://openalex.org/C43617362', 'wikidata': 'https://www.wikidata.org/wiki/Q170050', 'display_name': 'Chromatography', 'level': 1, 'score': 0.38127875}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.33973157}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.20406356}, {'id': 'https://openalex.org/C84393581', 'wikidata': 'https://www.wikidata.org/wiki/Q82642', 'display_name': 'Blood pressure', 'level': 2, 'score': 0.046073824}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-GLYZ200601014.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764396500', 'display_name': 'The Chinese Journal of Clinical Pharmacology', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4320800687', 'host_organization_name': 'Chinese Pharmaceutical Association', 'host_organization_lineage': ['https://openalex.org/P4320800687'], 'host_organization_lineage_names': ['Chinese Pharmaceutical Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2390450864', 'https://openalex.org/W2388799725', 'https://openalex.org/W2387989365', 'https://openalex.org/W2380574676', 'https://openalex.org/W2379755873', 'https://openalex.org/W2375623479', 'https://openalex.org/W2375372989', 'https://openalex.org/W2374073000', 'https://openalex.org/W2370049663', 'https://openalex.org/W2370037613', 'https://openalex.org/W2369411141', 'https://openalex.org/W2366790510', 'https://openalex.org/W2364732462', 'https://openalex.org/W2360271377', 'https://openalex.org/W2358159607', 'https://openalex.org/W2355539389', 'https://openalex.org/W2355425925', 'https://openalex.org/W2349701709', 'https://openalex.org/W2349695827', 'https://openalex.org/W2348914080'], 'abstract_inverted_index': {'Objective': [0], 'To': [1], 'study': [2], 'the': [3, 34, 63, 67, 121, 124], 'pharmacokinetics': [4], 'and': [5, 40, 66, 81, 94, 101, 109, 123], 'bioequivalence': [6], 'of': [7, 36, 62, 116], 'compound': [8], 'valsartan': [9, 39, 73], 'tablets': [10, 64, 122], 'in': [11], 'Chinese': [12], 'healthy': [13, 17], 'volunteers.': [14], 'Methods': [15], 'Twenty': [16], 'male': [18], 'voluteers': [19], 'were': [20, 44, 51, 70, 79, 87, 92, 107, 126], 'divided': [21], 'into': [22], '2': [23], 'groups.': [24], 'The': [25, 48, 58, 114], 'serum': [26], 'samples': [27], 'collected': [28], 'after': [29], 'a': [30], 'sigle': [31], 'oral': [32], 'at': [33], 'dose': [35], '160': [37], 'mg': [38, 42], '25': [41], 'hydrochlorothiazide': [43], 'determined': [45], 'by': [46, 53], 'RP-HPLC-fluorescence.': [47], 'pharmacokinetic': [49, 60], 'parameters': [50, 61], 'calculated': [52], 'BAPP': [54], '2.0': [55], 'software.': [56], 'Results': [57], 'main': [59], '(test)': [65], 'capsules': [68, 125], '(reference)': [69], 'as': [71], 'following:': [72], ':t_': [74], 'max': [75, 78, 91, 98], '(3.1±0.7)and': [76], '(3.0±0.7)h,C_': [77], '(4932.82±1557.19)': [80], '(4975.94±1472.51)μg·L': [82], '-1': [83, 89, 104, 111], ',': [84, 96], 'AUC_': [85], '0-t': [86, 106], '(30.54±10.73),(29.54±10.68)mg·h·L': [88], ';hydrochlorothiazide:t_': [90], '(2.2±0.9)': [93], '(2.2±0.6)h': [95], 'C_': [97], 'were(': [99], '196.04±13.95)': [100], '(185.77±16.350)': [102], 'μg·L': [103], ',AUC_': [105], '(1.29±0.23)': [108], '(1.34±0.28)mg·h·L': [110], '.': [112], 'Conclusion': [113], 'results': [115], 'statistics': [117], 'analysis': [118], 'shown': [119], 'that': [120], 'bioequivalent.': [127]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2361590022', 'counts_by_year': [], 'updated_date': '2024-09-15T07:12:25.285959', 'created_date': '2016-06-24'}